12th May 2021 12:47
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 11 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
444,819 | 0.20% | 1,794,617 | 0.80% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
161,781 | 0.07% | 7,021 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
630,800 | 0.28% | 1,825,838 | 0.81% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 253.9400 USD |
Purchase | 2 | 254.4600 USD |
Purchase | 4 | 255.9550 USD |
Purchase | 100 | 253.4500 USD |
Purchase | 100 | 254.0601 USD |
Purchase | 110 | 257.9000 USD |
Purchase | 200 | 253.7700 USD |
Purchase | 268 | 254.5601 USD |
Purchase | 300 | 255.9500 USD |
Purchase | 327 | 254.0857 USD |
Purchase | 609 | 254.0717 USD |
Purchase | 1,057 | 254.7754 USD |
Purchase | 1,582 | 254.1177 USD |
Purchase | 1,667 | 253.4302 USD |
Purchase | 1,726 | 254.0778 USD |
Purchase | 1,800 | 255.4900 USD |
Purchase | 1,900 | 254.7618 USD |
Purchase | 1,959 | 254.2085 USD |
Purchase | 3,917 | 254.2972 USD |
Purchase | 4,943 | 254.4157 USD |
Purchase | 5,891 | 254.1233 USD |
Purchase | 7,494 | 254.1200 USD |
Purchase | 7,986 | 253.9473 USD |
Purchase | 8,281 | 254.8665 USD |
Purchase | 9,720 | 253.8828 USD |
Purchase | 12,598 | 254.1300 USD |
Purchase | 14,139 | 254.2014 USD |
Purchase | 16,838 | 253.9213 USD |
Sale | 1 | 253.4000 USD |
Sale | 2 | 254.4600 USD |
Sale | 2 | 253.6650 USD |
Sale | 2 | 253.4050 USD |
Sale | 3 | 253.2783 USD |
Sale | 47 | 254.3800 USD |
Sale | 100 | 255.4300 USD |
Sale | 100 | 253.7100 USD |
Sale | 100 | 254.0900 USD |
Sale | 100 | 253.4700 USD |
Sale | 110 | 257.9000 USD |
Sale | 143 | 253.9793 USD |
Sale | 161 | 253.8895 USD |
Sale | 163 | 254.9885 USD |
Sale | 167 | 253.7906 USD |
Sale | 180 | 254.0266 USD |
Sale | 197 | 254.0269 USD |
Sale | 200 | 254.1400 USD |
Sale | 296 | 253.9036 USD |
Sale | 327 | 253.6946 USD |
Sale | 500 | 254.0940 USD |
Sale | 555 | 253.8786 USD |
Sale | 628 | 253.9576 USD |
Sale | 948 | 254.4026 USD |
Sale | 959 | 253.7892 USD |
Sale | 1,576 | 254.1207 USD |
Sale | 1,900 | 253.9476 USD |
Sale | 1,914 | 254.6121 USD |
Sale | 1,974 | 254.1236 USD |
Sale | 2,189 | 253.9781 USD |
Sale | 3,574 | 253.9231 USD |
Sale | 4,057 | 254.1165 USD |
Sale | 4,632 | 253.8374 USD |
Sale | 4,938 | 254.3342 USD |
Sale | 5,600 | 254.1200 USD |
Sale | 8,894 | 253.4325 USD |
Sale | 9,217 | 254.1315 USD |
Sale | 10,000 | 254.7589 USD |
Sale | 11,739 | 254.1097 USD |
Sale | 11,911 | 254.1675 USD |
Sale | 15,507 | 254.5545 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 12 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005525/en/
Copyright Business Wire 2021
Related Shares:
Aon Cl A OrdBarclays